Central Asian Research Index

Journal of Clinical Medicine of Kazakhstan, 2026, т. 23, № 2, с. 57-63

Multi-Biomarker Stratification of Coronary Artery Disease in Diabetic and Non-Diabetic Patients: Adiponectin, Inflammation, and Insulin Resistance

Leela Pattapu, Priya K Dhas, Mekhala K P, Ponnudhali D, Chakrapani Cheekavolu

PhD Scholar, Department of Biochemistry, Vinayaka Mission's Kirupananda Variyar Medical college and Hospitals, VMRF (DU), Salem, Tamil Nadu, India
Department of Biochemistry, Vinayaka Mission's Kirupananda Variyar Medical College, Vinayaka Mission's Research Foundation (Deemed to be University), Salem-636308, Tamil Nadu, India
Department of Biochemistry, Karpagam Faculty of Medical Science & Research, Coimbatore, Tamil Nadu, India
Department of Pharmacology, Karpagam Faculty of Medical Science & Research, Coimbatore, Tamil Nadu, India

Аннотация · Abstract

<b>ABSTRACT</b><br /> <b>Background:</b> Coronary artery disease [CAD] remains a leading cause of global mortality, with higher prevalence among individuals with type 2 diabetes mellitus [T2DM]. Limited data exist on biomarker interactions in CAD patients with and without T2DM.<br /> <b>Objective:</b> This study aimed to investigate correlations among adiponectin, inflammatory markers, and metabolic factors in CAD patients and evaluate their association with T2DM status.<br /> <b>Methods:</b> A cross-sectional study enrolled 225 participants: 75 healthy controls, 75 CAD patients with T2DM, and 75 CAD patients without T2DM. Serum levels of adiponectin, hs-CRP, IL-6, E-selectin, insulin, and C-peptide were measured using ELISA. Lipid profiles were analyzed via automated analyzer. Statistical analysis included ANOVA, correlation analysis, multicollinearity assessment, regression, and ROC analysis.<br /> <b>Results:</b> All biomarkers showed significant differences across groups [p&lt;0.05]. Adiponectin levels were lowest in CAD with T2DM [4.2 ± 1.0 mg/L vs 7.4 ± 1.6 mg/L in controls, p&lt;0.001]. Inflammatory markers were elevated in both CAD groups, with highest levels in diabetic patients. ROC analysis revealed moderate discriminative ability: adiponectin [AUC=0.79], hs-CRP [AUC=0.83], E-selectin [AUC=0.75], and insulin [AUC=0.72]. In the multivariable regression model, insulin emerged as the superior insulin-secretion marker over C-peptide, after accounting for multicollinearity and excluding participants with renal impairment.<br /> <b>Conclusion:</b> This study demonstrates significant associations between reduced adiponectin, elevated inflammatory markers, and metabolic dysfunction in CAD patients, particularly those with T2DM. An adiponectin threshold of ≤5.0 mg/L may serve as a practical clinical alert for high cardiovascular risk in diabetic patients. These findings warrant further prospective investigation to determine their potential clinical utility.

Сведения · Details